STOCK TITAN

Rezolute: Raymond Debbane may be deemed to own 6.1%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Rezolute, Inc. (RZLT) is the issuer in a Schedule 13G reporting that, as of November 13, 2026, Invus Public Equities, L.P. directly held 6,319,631 shares (5.3%) and Avicenna Life Sci Master Fund LP directly held 884,625 shares (0.7%).

Through control relationships, Raymond Debbane, managing member of Siren, L.L.C. and Ulys, L.L.C., may be deemed to beneficially own 7,204,256 shares (6.1%). Other entities in the respective control chains may also be deemed beneficial owners of the same holdings; those attributions overlap and are not separate amounts to add together.

Direct shares held by Invus Public Equities 6,319,631 shares As of November 13, 2026; reported beneficial ownership percentage was 5.3%.
Direct shares held by Avicenna Fund 884,625 shares As of November 13, 2026; reported beneficial ownership percentage was 0.7%.
Shares Raymond Debbane may be deemed to own 7,204,256 shares Reported beneficial ownership was 6.1%.
Shares outstanding 118,763,309 shares Following the closing of Rezolute’s public offering on November 16, 2026; used to calculate reported ownership percentages.
beneficially own regulatory
"may be deemed to beneficially own the Shares directly held"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Sole Voting Power regulatory
"Sole Voting Power 6,319,631.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power regulatory
"Sole Dispositive Power 6,319,631.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RZLT shares did Invus Public Equities and Avicenna Fund directly hold?

As of November 13, 2026, Invus Public Equities directly held 6,319,631 shares and Avicenna Life Sci Master Fund LP directly held 884,625 shares. Their reported ownership percentages were 5.3% and 0.7%, respectively.

How many RZLT shares may Raymond Debbane be deemed to own?

Raymond Debbane, managing member of Siren, L.L.C. and Ulys, L.L.C., may be deemed to beneficially own 7,204,256 shares, representing 6.1%. The reported percentage uses 118,763,309 shares outstanding following the public offering’s closing on November 16, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





76200L309

(CUSIP Number)
11/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Invus Public Equities, L.P.
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Date:11/19/2026
Invus Public Equities Advisors, LLC
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:11/19/2026
Invus Global Management, LLC
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:11/19/2026
Siren, L.L.C.
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:11/19/2026
Avicenna Life Sci Master Fund LP
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Date:11/19/2026
Avicenna Life Sci Master GP LLC
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, Chief Executive Officer
Date:11/19/2026
Ulys, L.L.C.
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:11/19/2026
Raymond Debbane
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane
Date:11/19/2026

Keep reading